Denkert Carsten, Weichert Wilko, Winzer Klaus-Jürgen, Müller Berit-Maria, Noske Aurelia, Niesporek Silvia, Kristiansen Glen, Guski Hans, Dietel Manfred, Hauptmann Steffen
Institute of Pathology, Charité Hospital, Berlin, Germany.
Clin Cancer Res. 2004 Aug 15;10(16):5580-6. doi: 10.1158/1078-0432.CCR-04-0070.
The human ELAV (embryonic lethal abnormal vision)-like protein HuR stabilizes a certain group of cellular mRNAs that contain AU-rich elements in their 3'-untranslated region. Cell culture studies have shown that the mRNA of cyclooxygenase (COX)-2 can be stabilized by HuR.
To investigate a possible contribution of dysregulation of mRNA stability to the progression of cancer and to overexpression of COX-2, we studied expression of HuR in 208 primary breast carcinomas by immunohistochemistry.
There were two different staining patterns of HuR in tumor tissue of breast carcinomas: nuclear expression was seen in 61% of cases; and an additional cytoplasmic expression was seen in 30% of cases. Expression of HuR was significantly associated with increased COX-2 expression; this association was particularly significant for cytoplasmic HuR expression (P < 0.0005). We further observed a significant association of cytoplasmic (P = 0.002) or nuclear HuR (P = 0.027) expression with increased tumor grade. Only 13% of the grade 1 carcinomas showed cytoplasmic expression of HuR, compared with 46% of the grade 3 carcinomas. There was no significant correlation between HuR expression and other clinicopathological parameters such as histological type, tumor size, or nodal status as well as patient survival.
Our results suggest that overexpression of HuR in tumor tissue may be part of a regulatory pathway that controls the mRNA stability of several important targets in tumor biology, such as COX-2. Based on our results, additional studies are necessary to investigate whether HuR might be a potential target for molecular tumor therapy.
人类ELAV(胚胎致死性视力异常)样蛋白HuR可稳定一类特定的细胞信使核糖核酸(mRNA),这些mRNA在其3'非翻译区含有富含AU的元件。细胞培养研究表明,环氧化酶(COX)-2的mRNA可被HuR稳定。
为了研究mRNA稳定性失调对癌症进展及COX-2过表达可能产生的影响,我们采用免疫组织化学方法研究了208例原发性乳腺癌中HuR的表达情况。
乳腺癌肿瘤组织中HuR有两种不同的染色模式:61%的病例可见细胞核表达;另外30%的病例可见细胞质表达。HuR的表达与COX-2表达增加显著相关;这种相关性在细胞质HuR表达中尤为显著(P<0.0005)。我们进一步观察到细胞质(P=0.002)或细胞核HuR(P=0.027)表达与肿瘤分级增加显著相关。1级癌中只有13%显示HuR的细胞质表达,而3级癌中这一比例为46%。HuR表达与其他临床病理参数如组织学类型、肿瘤大小、淋巴结状态以及患者生存率之间无显著相关性。
我们的结果表明,肿瘤组织中HuR的过表达可能是调控肿瘤生物学中几个重要靶点(如COX-2)mRNA稳定性的调节途径的一部分。基于我们的结果,有必要进行进一步研究以探讨HuR是否可能是分子肿瘤治疗的潜在靶点。